Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4271 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.30 USD | +3.77% | +19.13% | +28.91% | -46.08% | 51.28 M USD | ||
| 4273 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.50 USD | 0.00% | -10.71% | +4.17% | -48.45% | 49.04 M USD | ||
| 4277 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.87 USD | 0.00% | -5.90% | -51.27% | -69.82% | 48.59 M USD | ||
| 4293 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.22 USD | -0.81% | -0.81% | +0.83% | -15.28% | 46.09 M USD | ||
| 4294 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.29 USD | 0.00% | -6.45% | +3.57% | -83.33% | 46.31 M USD | ||
| 4295 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.13 USD | -3.18% | -4.05% | -7.39% | -46.48% | 44.81 M USD | ||
| 4297 |  CNTX Context Therapeutics Inc. - Common Stock | 0.48 USD | -4.00% | -7.69% | -21.31% | -46.07% | 44.10 M USD | ||
| 4300 |  MCRB Seres Therapeutics, Inc. - Common Stock | 4.54 USD | -0.44% | -0.66% | -8.84% | -44.84% | 45.13 M USD | ||
| 4302 |  VERU Veru Inc. - Common Stock | 2.51 USD | -4.92% | -5.99% | +7.26% | +5.02% | 42.80 M USD | ||
| 4310 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.85 USD | -5.61% | -5.61% | -75.17% | -80.81% | 41.96 M USD | ||
| 4315 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.44 USD | -4.59% | -2.28% | +41.23% | +592.47% | 41.93 M USD | ||
| 4327 |  EDSA Edesa Biotech, Inc. - Common Shares | 4.21 USD | -4.97% | -29.12% | -21.31% | +71.84% | 40.59 M USD | ||
| 4332 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.85 USD | -2.30% | +112.50% | +102.38% | -36.09% | 41.31 M USD | ||
| 4339 |  ALGS Aligos Therapeutics, Inc. - Common stock | 6.47 USD | -3.00% | -2.12% | +59.36% | -33.91% | 40.35 M USD | ||
| 4363 |  CRVO CervoMed Inc. - Common Stock | 2.61 USD | -0.38% | -2.25% | -4.40% | -71.69% | 39.46 M USD | ||
| 4406 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 USD | -11.30% | +4.64% | 0.00% | -39.83% | 31.41 M USD | ||
| 4409 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.09 USD | -2.68% | +2.83% | +25.29% | +4.81% | 34.27 M USD | ||
| 4417 |  QNCX Quince Therapeutics, Inc. - Common Stock | 33.00 USD | -2.74% | -5.53% | +86.97% | +1924.54% | 33.56 M USD | ||
| 4425 |  LITS Lite Strategy, Inc. - Common Stock | 1.00 USD | +1.01% | +11.11% | +2.04% | -66.44% | 34.03 M USD | ||
| 4436 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.72 USD | -2.70% | -4.00% | -4.00% | -20.88% | 31.32 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |